Browsing byAuthorWiens, A
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) |
| 2019-10-01 | Safety outcomes of disease-modifying therapies for relapsing–remitting multiple sclerosis: A network meta-analysis | Lucchetta, RC; Leonart, LP; Becker, J; Pontarolo, R; Fernandez-Llimós, F; Wiens, A |
| 2019-02-01 | Description of network meta-analysis geometry: A metrics design study | Tonin, FS; Borba, HH; Mendes, AM; Wiens, A; Fernandez-Llimos, F; Pontarolo, R |
| 2018-05-01 | IMMUNOMODULATORS AND IMMUNOSUPPRESSANTS FOR PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS | Lucchetta, RC; Tonin, FS; Borba, HH; Leonart, LP; Ferreira, VL; Bonetti, AF; Riveros, BS; Becker, J; Pontarolo, R; Fernandez-Llimos, F; Wiens, A |
| 2018-03-14 | Antioxidant effects of vitamins in type 2 diabetes: A meta-analysis of randomized controlled trials | Balbi, ME; Tonin, FS; Mendes, AM; Borba, HH; Wiens, A; Fernandez-Llimos, F; Pontarolo, R |
| 2017-12-01 | Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis | Tonin, FS; Steimbach, LM; Borba, HH; Sanches, AC; Wiens, A; Pontarolo, R; Fernandez-Llimos, F |
| 2017-03-01 | Efficacy and safety of amphotericin B lipid-based formulations—A systematic review and meta-analysis | Steimbach, LM; Tonin, FS; Virtuoso, S; Borba, HHL; Sanches, ACC; Wiens, A; Fernandez-Llimós, F; Pontarolo, R |
| 2017-01-01 | Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24 | Borba, HH; Wiens, A; Steimbach, LM; Perlin, CM; Tonin, FS; Pedroso, MLA; Fernandez-Llimos, F; Pontarolo, R |
| 2017-01-01 | Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: A multicenter longitudinal study | Borba, HHL; Wiens, A; Steimbach, LM; Tonin, FS; Pedroso, MLA; Ivantes, CAP; Fernandez-Llimos, F; Pontarolo, R |
